Results: 13
Acknowledgment to Referees.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 595, doi. 10.1007/s40256-023-00617-1
- Publication type:
- Article
Colchicine for the Prevention of Recurrent Arrhythmia After Catheter Ablation of Atrial Fibrillation: Results of a Single-Center, Retrospective Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 709, doi. 10.1007/s40256-023-00612-6
- By:
- Publication type:
- Article
Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 721, doi. 10.1007/s40256-023-00611-7
- By:
- Publication type:
- Article
The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 601, doi. 10.1007/s40256-023-00610-8
- By:
- Publication type:
- Article
Novel Therapeutic Avenues for Hypertrophic Cardiomyopathy.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 623, doi. 10.1007/s40256-023-00609-1
- By:
- Publication type:
- Article
Double Trouble: The Challenge of Neuroprotection in Patients with Liver Cirrhosis and Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 599, doi. 10.1007/s40256-023-00608-2
- By:
- Publication type:
- Article
Bempedoic Acid can Reduce Cardiovascular Events in Combination with Statins or As Monotherapy: A Systematic Review and Meta-analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 695, doi. 10.1007/s40256-023-00606-4
- By:
- Publication type:
- Article
The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 663, doi. 10.1007/s40256-023-00605-5
- By:
- Publication type:
- Article
Correction: Ticagrelor or Clopidogrel as Antiplatelet Agents in Patients with Chronic Kidney Disease and Cardiovascular Disease: A Meta‑analysis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 641, doi. 10.1007/s40256-023-00602-8
- By:
- Publication type:
- Article
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 609, doi. 10.1007/s40256-023-00601-9
- By:
- Publication type:
- Article
Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 6, p. 683, doi. 10.1007/s40256-023-00598-1
- By:
- Publication type:
- Article
Correction to: Etripamil Nasal Spray: Therapeutic Potential for Treating Paroxysmal Supraventricular Tachycardia.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice